CytoDyn Market Cap

CytoDyn has a market cap or net worth of $295.59 million as of March 26, 2025. Its market cap has increased by 58.95% in one year.

Market Cap

295.59M

Enterprise Value

303.00M

Revenue

n/a

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.24

Market Cap Chart

Since November 17, 2005, CytoDyn's market cap has increased from 5.54M to 295.59M, an increase of 5,237.95%. That is a compound annual growth rate of 22.80%.

Market Cap History

Date	Market Cap	% Change
Mar 25, 2025	295.59M	119.55%
Dec 31, 2024	134.63M	-29.42%
Dec 29, 2023	190.74M	2.63%
Dec 30, 2022	185.85M	-72.64%
Dec 31, 2021	679.28M	-78.86%
Dec 31, 2020	3.21B	695.20%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Endo Inc.	1.94B
SS Innovations International	1.76B
Nika Pharmaceuticals	1.02B
Veradigm	763.10M
Elite Pharmaceuticals	490.07M
Glass House Brands	356.32M
Northwest Biotherapeutics	343.07M
BioStem Technologies	180.20M

Market Cap Rankings